UNIGE document Scientific Article - Review
previous document  unige:40735  next document
add to browser collection

Humoral rejection of organ allografts

Pascual, Manuel
Published in American Journal of Transplantation. 2005, vol. 5, no. 11, p. 2611-8
Abstract In recent years, the deleterious clinical consequences of recipient de novo alloantibody production against HLA antigens from human organ allografts have been extensively investigated. In kidney transplantation, the identification of the complement C4d fragment in peritubular capillaries as a specific marker for humoral rejection has helped to define and characterize distinct clinical alloantibody-mediated syndromes. This knowledge is relevant for patient management as new therapeutic strategies to remove and control anti-donor antibody production, particularly in the setting of acute humoral rejection, have been reported. For recipients of nonrenal organ allografts such as heart transplant recipients, de novo anti-HLA alloantibody may also be important, although more studies are needed before clear guidelines can be proposed.
Keywords Acute DiseaseAntibody FormationGraft Rejection/immunologyHumansKidney Transplantation/immunology/pathologyOrgan TransplantationTransplantation, Homologous/immunology
PMID: 16212619
Full text
Article (Author postprint) (308 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Analyse protéomique et Analyse génomique des maladies rénales (659)
(ISO format)
MOLL, Solange, PASCUAL, Manuel. Humoral rejection of organ allografts. In: American Journal of Transplantation, 2005, vol. 5, n° 11, p. 2611-8. https://archive-ouverte.unige.ch/unige:40735

248 hits

0 download


Deposited on : 2014-10-07

Export document
Format :
Citation style :